Study finds robotic-assisted prostate surgery offers better cancer control

by Shaun Mason

An observational study from UCLA's Jonsson Comprehensive Cancer Center has found that prostate cancer patients who undergo robotic-assisted prostate surgery have fewer instances of cancer cells at the edge of their surgical specimen and less need for additional cancer treatments like hormone or radiation therapy than patients who have traditional "open" surgery.

The study, published online Feb. 19 in the journal European Urology, was led by Dr. Jim Hu, UCLA's Henry E. Singleton Professor of Urology and director of robotic and in the urology department at the David Geffen School of Medicine at UCLA.

Although it is becoming more popular, robotic-assisted radical prostatectomy—the complete removal of the prostate using a robotic apparatus—remains controversial because there has been little evidence that it provides better cancer control than open radical prostatectomy, the traditional surgical approach, which is less costly.

In an effort to determine whether or not robotic surgery offered an advantage, Hu and his colleagues compared 5,556 patients who received robotic surgery with 7,878 who underwent between 2004 and 2009. Data was provided by the Surveillance, Epidemiology, and End Results–Medicare, a program of cancer registries that collect clinical and demographic information on people with cancer.

The researchers looked at the surgical margin status of the two groups, which is the amount of cancer cells at the edge of the removed prostate specimen. A positive margin—the presence of at the edge—may result from cutting through the cancer and leaving some behind rather than cutting around the cancer completely. In , this has been shown to lead to a greater risk of recurrence and death from the disease.

The team also assessed the use of additional cancer therapies—a hormone therapy known as androgen deprivation, as well as radiation—after robotic surgery and open surgery.

They found that robotic was associated with 5 percent fewer positive margins (13.6 percent vs. 18.3 percent); this difference was greater for patients with intermediate and high-risk prostate cancer. Patients who had robotic surgery also had a one-third reduction in the likelihood of needing additional cancer therapies within 24 months after surgery.

Despite the greater up-front cost of , the findings show that the procedure may translate into less downstream costs and fewer side effects from radiation and hormone therapy, the researchers said.

More information: "Comparative Effectiveness of Robot-assisted Versus Open Radical Prostatectomy Cancer Control." Jim C. Hu, et al. European Urology PII: S0302-2838(14)00134-1 DOI: 10.1016/j.eururo.2014.02.015

add to favorites email to friend print save as pdf

Related Stories

Study: Ureteral injury during robot-assisted prostate surgery

Nov 19, 2013

There may be warning signs to help surgeons avoid damaging part of the urinary system during robot-assisted surgical removal of prostate cancer, ultimately preventing the expense of additional surgery, according to researchers ...

Prostate cancer -- robotic surgery may be best option

Sep 08, 2011

Prostate cancer is a significant public health concern and cause of morbidity among men in the United States. In 2011, it is estimated that 240,890 new cases of prostate cancer will be diagnosed and almost 34,000 men will ...

Recommended for you

New breast cancer imaging method promising

4 hours ago

The new PAMmography method for imaging breast cancer developed by the University of Twente's MIRA research institute and the Medisch Spectrum Twente hospital appears to be a promising new method that could ...

Palliation is rarely a topic in studies on advanced cancer

5 hours ago

End-of-life aspects, the corresponding terminology, and the relevance of palliation in advanced cancer are often not considered in publications on randomized controlled trials (RCTs). This is the result of an analysis by ...

Breast cancer replicates brain development process

5 hours ago

New research led by a scientist at the University of York reveals that a process that forms a key element in the development of the nervous system may also play a pivotal role in the spread of breast cancer.

User comments